Are IO's actually that painful to insert? Can they be used in awake patients? This is over-dramatized. Yes, they can be used in awake patients. One study assessed the pain associated with humeral IO insertion and removal finding a mean reported pain of 3.9 and 2.2 on a 10-scale, respectively.

Can the blood bank run out of blood? Well, yes, and no. Every hospital has their own thresholds for which they can request additional resources. This is sometimes referred to as a "catastrophic" activation.

#tbt 2023 versus 2016... Fort Bliss the sign was a lot cooler 😎 back in 2016 #emergency #emergencymedicine #military #army #armyemdoc

RCT published in Crit Care this week finds no benefit to prone positioning 🛌 in hypoxic COVID-19 patients with regards to: -Progression to NIV or intubation -Death Major limitations: -Median time prone per day was 90m, goal was 2h -Only 1/3 of those assigned proning qualified for the per-protocol

When it comes to airway, there's not too many things worse than an unrecognized tube in the goose. This systematic review assessed clinical methods when the gold standard waveform ETCO2 is not available: Misting = 🗑 🗑 (FP=69%) Auscultation = 🗑 (FP=18%) Colormetric CO2 = 🤏 (FP=5%)

Acute subdurals are easy to manage from the ED standpoint. Chronic subdurals, not so much. It's often something we find incidentally, and they may or may not have symptoms (e.g. fell down, hit head, no symptoms, etc.). The DESCA trial came out this week, and sheds light on what doesn't work.

The DHA and 59MDW funded DEVICE trial results are out. It's clear that video laryngoscopy is superior to direct laryngoscopy. The military needs to field VL technology to every medical footprint on the battlefield. Time now.

The results from our DEVICE trial are out in the @NEJM . In this RCT, direct laryngoscopy was inferior to video laryngoscopy for first-pass success. In fact, it was so inferior that we had to stop the trial early after DSMB review due to the clear benefit of VL.

🔥 off the press (hours ago) in @NEJM, the PATCH trial finds no benefit with prehospital TXA at 6 months based on GOSE.